CH357395A - Process for the preparation of new hydrazine derivatives - Google Patents

Process for the preparation of new hydrazine derivatives

Info

Publication number
CH357395A
CH357395A CH357395DA CH357395A CH 357395 A CH357395 A CH 357395A CH 357395D A CH357395D A CH 357395DA CH 357395 A CH357395 A CH 357395A
Authority
CH
Switzerland
Prior art keywords
hydrazine
isopropylidene
piperidyl
methyl
solution
Prior art date
Application number
Other languages
German (de)
Inventor
Ernst Dr Jucker
Erwin Dr Rissi
Rudolf Dr Sueess
Arnold Dr Vogel
Eberhard Dr Wolff
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH357395A publication Critical patent/CH357395A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

  



  Verfahren zur Herstellung von neuen Hydrazin-Derivaten
Es wurde gefunden, dass man zu neuen Hydrazin Derivaten der Formel I
EMI1.1     
 gelangen kann, indem man   (1-Methyl-piperidyl-4)-    hydrazin der Formel II
EMI1.2     
 mit Aceton umsetzt, das   entstandene-(l-Methyl-      piperidyl-4)-cv'-isopropyliden-hydrazin    durch Behandeln mit   Carbonsäurechloriden    der Formel III,    RI-COCU    III wobei   Ri    obige Bedeutung besitzt, acyliert und aus dem so entstandenen acylierten   (I,-(l-Methyl-piperi-      dyl-4)-og'. isopropyliden-hydrazin    die   Isopropyliden-    gruppe abspaltet.



   Beispiel 1 or   phenoxy-hydrazin       J 00 g 1-Methyl-piperidyl-4-hydrazin werden    in 300 cm3 Aceton unter Kühlung gelöst und die Lösung   1/2    Std. am Rückfluss zum Sieden erhitzt. Eindampfen der Lösung im Vakuum liefert das   cl- (1-      Methyl-piperidyl-4)-og'-isopropyliden-hydrazin    in quantitativer Ausbeute. Es kristallisiert beim   Abküh-    len in Nadeln. Die Verbindung kann destilliert werden und siedet bei   6870 l0,      3    mm Hg. Zur Acylierung wird jedoch das kristalline Rohprodukt direkt weiter verwendet.



   Eine Lösung von   31,    1 g   or (1-Methyl-piperidyl-4)-      co'-isopropyliden-hydrazin    in 100 cm   Methylen-    chlorid wird unter Rühren und Kühlung (Innentemperatur   0-10 )    tropfenweise mit der Lösung von 28,83 g   Chlorameisensäure-phenylester    in 30 cm3 Methylenchlorid versetzt. Nach beendeter Zugabe wird die Lösung 2 Std. bei Zimmertemperatur weitergerührt, dann mit   20proz.,    mit Kochsalz gesättigter,   auf-10  abgekühlter    Natronlauge ausgeschüttelt, über Natriumsulfat getrocknet und im Vakuum eingedampft.

   Der Rückstand wird im Hochvakuum fraktioniert, wobei das   co-(l-Methyl-pipefidyl-4)-oo-carbo-      phenoxy-cv'-isopropyliden-hydrazin    unter 0,2 mm Hg bei 132-139  übergeht.



   16,12   g- (1-Methyl-piperidyl-4)-oo-carbo-      phenoxy-ct,'-isopropyliden-hydrazin    werden in 75 cm3 90proz. Äthanol gelöst und in die Lösung bei   0     Chlorwasserstoff bis zur kongosauren Reaktion eingeleitet. Darauf wird die Lösung 1 Std. bei Zimmertemperatur stehen gelassen und alsdann im Vakuum bei einer Badtemperatur von   40     fast zur Trockne eingeengt. Der Rückstand wird in Chloroform aufgenommen, die   Chloroformlösung    mit 20proz., mit Kochsalz gesättigter,   auf-10     abgekühlter Natron lauge ausgeschüttelt, über Natriumsulfat getrocknet und im Vakuum zur Trockne eingedampft. Der kristalline Rückstand wird aus   Äther-Petroläther    umkristallisiert.

   Reines   og-      (1-Methyl-piperidyl-4)-co-      carbophenoxy-hydrazin    schmilzt bei 79-80 .



   Beispiel 2   - (1-Methyl-piperidyl-4)-u-benzoyl-hydrazin   
Eine Lösung von 29,25 g   co- (1-Methyl-piperidyl-      4)-os'-isopropyliden-hydrazin    (Herstellung siehe Beispiel   1,    1. Absatz) in 100 cm3 Chloroform wird unter Rühren bei   0     tropfenweise mit 24,25 g Benzoylchlorid versetzt. Nach beendeter Zugabe wird die Lösung noch 16 Std. bei Zimmertemperatur stehen gelassen. Die Aufarbeitung erfolgt wie im Beispiel 1 beschrieben. Das   (, j- (1-Methyl-piperidyl-4)-      ss-benzoyl-ct)'-isopropyliden-hydrazin destilliert    im Hochvakuum unter 0,004 mm Hg bei einer Badtemperatur von   145 .   



   27,4 g   co-(1-Methyl-piperidyl-4)-co-benzoyl-x'-    isopropyliden-hydrazin werden in 250 cm3 90proz.



  Äthanol gelöst und wie im Beispiel 1 beschrieben hydrolysiert und aufgearbeitet. Der kristalline   Rück-    stand, das   ou-      (1-Methyl-piperidyl-4)-c,-benzoyl-    hydrazin, wird aus Benzol umkristallisiert. Smp. 146 bis   148 .   



   Beispiel 3   Oo-Methyl-piperidyl4)-co-benzylsalicoyl-hydrazin   
Eine Lösung von 3,39   g v- (1-Methyl-piperidyl-4)-      og'-isopropyliden-hydrazin    (Herstellung siehe Beispiel   1,    1. Absatz) in 100 cm3 Methylenchlorid wird unter Rühren   undKühlung    (Innentemperatur   0-10 )    tropfenweise mit einer Lösung von 4,93 g Benzylsalicylsäurechlorid in 30 cm3 Methylenchlorid versetzt. Nach beendeter Zugabe wird das Gemisch   31/2    Std. bei Zimmertemperatur weitergerührt, dann mit eiskalter, 20proz., mit Kochsalz gesättigter Natronlauge ausgeschüttelt, über Natriumsulfat getrocknet und im Vakuum eingedampft.

   Der ölige Rückstand wird im Hochvakuum fraktioniert, wobei das   oo-(l-Me-      thyl-piperidyl-4)-co-benzylsalicoyl-os'-isopropyliden-    hydrazin bei einer Luftbadtemperatur von 210-240  übergeht.



   6,0 g   o-(l-Methyl-piperidyl-4)-ou-benzylsali      os'-isopropyliden-hydrazin    werden in 35 cm3 90proz. Äthanol gelöst und in die Lösung unter Kühlung bei 0-10  Chlorwasserstoff bis zur kongosauren Reaktion eingeleitet. Darauf wird die Lösung 1 Std. bei Zimmertemperatur stehen gelassen und anschliessend im Vakuum zur Trockne eingedampft. Der Rückstand wird in Chloroform aufgenommen, die Chloroformlösung mit 20proz.,   auf-5"abgekühlter,    mit Kochsalz gesättigter Natronlauge ausgeschüttelt, über Natriumsulfat getrocknet und im Vakuum eingedampft.



  Der ölige Rückstand wird im Hochvakuum destilliert, wobei das   co-(l-Methyl-piperidyl-4)-oo-benzylsalicoyl-    hydrazin bei einer Luftbadtemperatur von etwa 270  übergeht.



  



  Process for the preparation of new hydrazine derivatives
It has been found that new hydrazine derivatives of the formula I
EMI1.1
 can be achieved by (1-methyl-piperidyl-4) - hydrazine of the formula II
EMI1.2
 reacts with acetone, the resulting- (l-methylpiperidyl-4) -cv'-isopropylidene hydrazine by treatment with carboxylic acid chlorides of the formula III, RI-COCU III where Ri has the above meaning, acylated and from the acylated (I - (1-Methyl-piperidyl-4) -og '. isopropylidene hydrazine splits off the isopropylidene group.



   Example 1 or phenoxy-hydrazine J 00 g of 1-methyl-piperidyl-4-hydrazine are dissolved in 300 cm 3 of acetone with cooling and the solution is heated to boiling under reflux for 1/2 hour. Evaporation of the solution in vacuo gives the cl- (1-methyl-piperidyl-4) -og'-isopropylidene hydrazine in quantitative yield. It crystallizes in needles on cooling. The compound can be distilled and boils at 6870 l0.3 mm Hg. For the acylation, however, the crystalline crude product is used directly further.



   A solution of 31.1 g of or (1-methyl-piperidyl-4) - co'-isopropylidene hydrazine in 100 cm of methylene chloride is added dropwise with the solution of 28.83 g while stirring and cooling (internal temperature 0-10) Phenyl chloroformate was added to 30 cm3 of methylene chloride. After the addition is complete, the solution is stirred for a further 2 hours at room temperature, then extracted by shaking with 20% sodium hydroxide solution saturated with sodium chloride, cooled to 10, dried over sodium sulfate and evaporated in vacuo.

   The residue is fractionated in a high vacuum, the co- (1-methyl-pipefidyl-4) -oo-carbo-phenoxy-cv'-isopropylidene-hydrazine under 0.2 mm Hg at 132-139.



   16.12 g- (1-methyl-piperidyl-4) -oo-carbo-phenoxy-ct, '- isopropylidene-hydrazine are 90% in 75 cm3. Dissolved ethanol and introduced into the solution at 0 hydrogen chloride until the Congo acidic reaction. The solution is then left to stand for 1 hour at room temperature and then concentrated to almost dryness in vacuo at a bath temperature of 40. The residue is taken up in chloroform, the chloroform solution extracted with 20% sodium hydroxide solution, saturated with sodium chloride, cooled to 10, dried over sodium sulfate and evaporated to dryness in vacuo. The crystalline residue is recrystallized from ether-petroleum ether.

   Pure og- (1-methyl-piperidyl-4) -co-carbophenoxy-hydrazine melts at 79-80.



   Example 2 - (1-methyl-piperidyl-4) -u-benzoylhydrazine
A solution of 29.25 g of co- (1-methyl-piperidyl-4) -os'-isopropylidene-hydrazine (preparation see Example 1, 1st paragraph) in 100 cm3 of chloroform is added dropwise with 24.25 g while stirring at 0 Benzoyl chloride added. After the addition has ended, the solution is left to stand for a further 16 hours at room temperature. Working up is carried out as described in Example 1. The (, j- (1-methyl-piperidyl-4) - ss-benzoyl-ct) '- isopropylidene hydrazine distilled in a high vacuum below 0.004 mm Hg at a bath temperature of 145.



   27.4 g of co- (1-methyl-piperidyl-4) -co-benzoyl-x'-isopropylidene hydrazine are 90% in 250 cm3.



  Dissolved ethanol and hydrolyzed and worked up as described in Example 1. The crystalline residue, the ou (1-methylpiperidyl-4) -c, -benzoylhydrazine, is recrystallized from benzene. M.p. 146 to 148.



   Example 3 Oo-methyl-piperidyl4) -co-benzylsalicoylhydrazine
A solution of 3.39 g of v- (1-methyl-piperidyl-4) - og'-isopropylidene hydrazine (for preparation see Example 1, 1st paragraph) in 100 cm3 of methylene chloride is added dropwise with stirring and cooling (internal temperature 0-10) a solution of 4.93 g of benzylsalicylic acid chloride in 30 cm3 of methylene chloride is added. After the addition has ended, the mixture is stirred for another 31/2 hours at room temperature, then extracted with ice-cold 20% sodium hydroxide solution saturated with sodium chloride, dried over sodium sulfate and evaporated in vacuo.

   The oily residue is fractionated in a high vacuum, the oo- (1-methylpiperidyl-4) -co-benzylsalicoyl-os'-isopropylidene hydrazine passing over at an air bath temperature of 210-240.



   6.0 g of o- (l-methyl-piperidyl-4) -ou-benzylsali os'-isopropylidene hydrazine are 90 percent in 35 cm3. Dissolved ethanol and introduced into the solution with cooling at 0-10 hydrogen chloride until the Congo acidic reaction. The solution is then left to stand for 1 hour at room temperature and then evaporated to dryness in vacuo. The residue is taken up in chloroform, the chloroform solution is extracted with 20% sodium hydroxide solution cooled to 5 "and saturated with sodium chloride, dried over sodium sulfate and evaporated in vacuo.



  The oily residue is distilled in a high vacuum, the co- (1-methylpiperidyl-4) -oo-benzylsalicoylhydrazine passing over at an air bath temperature of about 270.

 

Claims (1)

PATENTANSPRUCH Verfahren zur Herstellung von neuen Hydrazin Derivaten der Formel 1 EMI2.1 dadurch gekennzeichnet, dass man (1-Methyl-piperi- dyl-4)-hydrazin der Formel II EMI2.2 mit Aceton umsetzt, das entstandene w- (1-Methyl- piperidyl-4)-co'-isopropyliden-hydrazin durch Behandeln mit Carbonsäurechloriden der Formel III, Ri-COCI III wobei Ri obige Bedeutung besitzt, acyliert und aus dem so entstandenen acylierten au-(l-MethyI-piperi- dyl-4)-co'-isopropyliden-hydrazin die Isopropyliden- gruppe abspaltet. PATENT CLAIM Process for the preparation of new hydrazine derivatives of formula 1 EMI2.1 characterized in that (1-methyl-piperidyl-4) hydrazine of the formula II EMI2.2 reacts with acetone, the resulting w- (1-methylpiperidyl-4) -co'-isopropylidene hydrazine by treatment with carboxylic acid chlorides of the formula III, Ri-COCI III where Ri has the above meaning, acylated and from the acylated au - (l-MethyI-piperidyl-4) -co'-isopropylidene hydrazine splits off the isopropylidene group.
CH357395D 1958-05-06 1958-06-09 Process for the preparation of new hydrazine derivatives CH357395A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH354441T 1958-05-06
CH357395T 1958-06-09

Publications (1)

Publication Number Publication Date
CH357395A true CH357395A (en) 1961-10-15

Family

ID=25737139

Family Applications (1)

Application Number Title Priority Date Filing Date
CH357395D CH357395A (en) 1958-05-06 1958-06-09 Process for the preparation of new hydrazine derivatives

Country Status (1)

Country Link
CH (1) CH357395A (en)

Similar Documents

Publication Publication Date Title
Toki Studies on sarkomycin–optically active 2-methylenecyclopentanone-3-carboxylic acids
AT202152B (en) Process for the preparation of new dimethylaminopropylidene thiaxanthenes.
AT263229B (en) Process for the production of new 3-OR-11-Oxo-16-androstenes
AT261130B (en) Process for the production of the new 3.2 Dioxo 17α methyl 19 nor pregna 4,9,11 triens
AT226235B (en) Process for the preparation of new thioxanthene derivatives
AT268548B (en) Process for the preparation of triene derivatives of steroids
AT215993B (en) Process for the preparation of new 4-oxo-2- (haloalkyl) -2,3-dihydro- [benzo-1,3-oxazines]
AT152837B (en) Process for the preparation of 2.4-dioxo-3.3-dialkyl-1.2.3.4-tatrahydropyridines.
AT153509B (en) Process for the preparation of 4-alkyl-5-oxyalkylthiazoles.
AT224125B (en) Process for the preparation of new thioxanthene derivatives
AT231450B (en) Process for the preparation of the new 2-amino-3-methoxypyrazine
DE697801C (en) Process for the preparation of furan compounds of the pyrazolone series
DE730728C (en) Process for the preparation of an acid of dimethanesulfonic acid imide
AT217994B (en) Process for the preparation of new derivatives of polyhydroxy alcohols
AT236937B (en) Process for the production of new basic substituted anthradipyrazoles
DE1543418C3 (en) Process for the preparation of 2,3,4-trimethoxy-5- (2'-carboxyethyl) -6oxo-5,6,8,9-tetrahydro-7H-benzocycloheptene
AT230389B (en) Process for the preparation of new thioxanthene derivatives
AT218006B (en) Process for the preparation of new 2-acyl-4-aminophenol ethers and their salts
AT200581B (en) Process for the production of new guanidine compounds
CH406245A (en) Process for the preparation of oxybenzoic acid ethers
CH357721A (en) Process for the preparation of a new hydrazine derivative
CH207498A (en) Process for the preparation of a derivative of the 3-keto-cyclopentanopolyhydrophenanthrene series.
CH339213A (en) Process for the preparation of substituted nortropine ethers
CH363658A (en) Process for the production of new scopin ethers
CH361566A (en) Process for the preparation of thiol and thionothiol phosphoric acid esters